Using Nicotine to Reverse Age-related Auditory Processing Deficits
Sponsor: University of California, Irvine • ClinicalTrials.gov ID: NCT04971954
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The present study will evaluate the effects of both aging and nicotine on psychophysical tasks and electrophysiological measures. Nicotine will be administered to study participants in the form of gum that is available as an over-the-counter medication. The hypothesis is that nicotine will reverse the detrimental effects of aging on auditory processing. The proposed experiments will characterize the effects of nicotine and may eventually lead to improved treatments of hearing loss in a variety of patient populations and in healthy aging.
Interventions
-
Nicotine gum
(Other)
Nicotine (6 mg) will be administered in the form of polacrilex gum that is available as an over-the-counter medication
-
Placebo gum
(Other)
The placebo will also be a commercially available gum that resembles the nicotine gum in flavor, size, shape, color, and texture.
Eligibility criteria
Conditions
Locations
- Hearing and Speech Lab — Irvine, California, United States
- San Diego State University — San Diego, California, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record